FOCUS Bipolar: Families Opening Conversations for Understanding Signs
University of Texas Southwestern Medical Center · with The Texas Child Mental Health Care Consortium (TCMHCC) · NCT07622927
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 7+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 200
- US sites recruiting
- 1
- Study start
- March 11, 2026
- Record last updated
- June 3, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Bipolar disorder often runs in families, but early symptoms in youth can go unrecognized for years. This project evaluates a structured, family-centered approach to informed screening for youth ages 7-21 who have a biological parent with bipolar disorder.
The main questions addressed by this project are:
Whether a co-designed video decision aid improves caregiver understanding of bipolar disorder genetic risk and supports informed decisions about youth screening.
Whether remote mental health screening tools are feasible and acceptable for youth with familial risk for bipolar disorder.
Whether screening results can be used to identify early risk patterns and inform tailored follow-up recommendations.
Participants may be involved in one or more study activities, including co-design of educational decision-aid content, feedback on decision-aid prototypes, beta testing of the decision aid, and remote youth mental health screening. The study does not assign treatment and does not change existing clinical care or clinic routines.
Being studied: Co-design Workshop (Observational Procedure); Alpha Testing (Observational Procedure); Beta Testing (Observational Procedure); Youth Screening Pathway & Brief Follow-Up Interview (Observational Procedure)
Conditions: Bipolar Disorder (BD); Bipolar Disorder I or II; Bipolar Disorder Family Members; Screening Tool
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria for Group A - Parent with Bipolar Disorder:
- Age: 18 years or older.
- Confirmation of a lifetime Bipolar I or II diagnosis
- Parent status: Has at least one biological child aged 7-21 years.
- Capacity and willingness to consent: Able and willing to provide informed consent.
- Study participation: Able to comply with study procedures (e.g., co-design sessions, interviews, assessments).
- Language: Able to read, speak, and understand English.
Inclusion Criteria for Group B - Adult Caregiver:
- Age: 18 years or older.
- Caregiver status: The adult primarily responsible for the daily care and/or medical decisions for ≥ 6 months for a child aged 7-21 years whose biological parent has a lifetime, clinician-confirmed diagnosis of Bipolar I or II disorder.
- Capacity and willingness to consent: Able and willing to provide informed consent.
- Study participation: Able to comply with study procedures (e.g., co-design sessions, interviews, assessments).
- Language: Able to read, speak, and understand English.
Inclusion Criteria for Group C - At-Risk Youth:
- Age:
- Phase 1 (co-design) and Phase 2A (alpha testing): 13-18 years
- Phase 2B (beta testing): 13-18 years
- Phase 3 (screening): 7-21 years
- Diagnosis status: Must not have a current diagnosis of Bipolar I or II disorder.
- Parental diagnosis: Has at least 1 biological parent with a lifetime, clinician-confirmed Bipolar I or II diagnosis (as defined in Groups A and B).
- Consent/Assent:
- For youth aged 18-21: Able and willing to provide informed consent (verbal)
- For youth aged 7-21: Parent/guardian/LAR able and willing to provide informed consent (verbal) and youth able to provide assent (verbal)
- Participant ability: Able and willing to participate in study activities (e.g., co-design discussions, questionnaires, or screening assessments.
- Language: English sufficient to comprehend study procedures and materials.
Criteria for Exclusion of Participants
A potential participant will NOT be eligible for participation in this study if any of the following criteria are met:
- Unable to provide informed consent due to cognitive impairment or language barriers
- Experiencing acute psychiatric instability at enrollment (e.g., acute psychosis or acute suicidality without stabilization)
- Has a medical or psychiatric condition that, in the judgment of the Principal Investigator or study clinician, would place undue risk on the individual or interfere with standard clinical care
Recruiting US locations
UT Southwestern Medical Center
Dallas, TX 75390
Site contact: Karabi Nandy, Ph.D. · 214-648-9551 · FOCUSBipolar@UTSouthwestern.edu
Study contacts (from the official record)
- Karabi Nandy, Ph.D. · 214-648-4490 · FOCUSBipolar@UTSouthwestern.edu
- Karabi Nandy, Ph.D. · 214-648-9551 · FOCUSBipolar@UTSouthwestern.edu
Similar studies in Texas
All mental health studies in Texas →- RecruitingPhase 1Overnight stay mentioned
A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
Leal Therapeutics, Inc
- Location
- Richardson, TX + 9 other US sites
- Eligibility basics
- Ages 18–55
- RecruitingPhase 1Overnight stay mentioned
Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
BioXcel Therapeutics Inc
- Location
- DeSoto, TX + 3 other US sites
- Eligibility basics
- Ages 10–17
- RecruitingHealthy volunteersPhase 1
Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant Depression
Texas A&M University
- Location
- Houston, TX + 1 other US site
- Eligibility basics
- Ages 21–45
- RecruitingHealthy volunteersPhase 1
ACT for Individuals With MNCD and Their Care Partners
Texas Tech University
- Location
- Lubbock, TX
- Eligibility basics
- Ages 18+